Top Markets
#1 Akedo Akedo +63.33%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.58%
#4 Cross Cross +34.01%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cap Cap +32.66%
#7 Velvet Velvet +25.73%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.06%
#9 Ravencoin Ravencoin +13.84%
#10 DoubleZero DoubleZero +13.55%
Coin of the day
Akedo Akedo
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Pozycja w akcjach #38911
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Cena akcji
$0.1645
Kapitalizacja rynkowa
$681.26K
Zmiana (1 dzień)
-3.69%
Zmiana (1 rok)
-95.30%
Kraj
US
Handel Valion Bio, Inc. (VBIO)

Kategoria

Healthcare
Historia ceny akcji dla Valion Bio, Inc. (VBIO)
Najwyższa cena zamknięcia: $0.24 dnia 2026-08-01

Najniższa cena zamknięcia: $7.60K dnia 2021-11-01
Historia cen akcji firmy Valion Bio, Inc. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -21.26%
2025 -56.71%
2024 -86.09%
2023 -97.85%
2022 -79.33%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.40 29.49%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $842.41 29.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $726.49 6.37%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.46 11.09%
BE